Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MONTPARK
2023-504278-39-00Phase 2Authorised
- Sponsor
- Karolinska University Hospital
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Montelukast buccal film with Placebo buccal film (2 arms). Primary endpoint: Change in MDS-UPDRS Part 3 motor score from baseline to month 18 in OFF-medication state. Planned start Oct 2023; status: authorised.
02
Drugs
montelukast
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2023-504278-39-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504278-39-00.